Odonate IncOTC Pink - Limited Information:ODTCD
- LAST PRICE17,100.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots17,100.0000/ 1
- Ask / Lots22,000.0000/ 1
- Open / Previous Close0.0000 / 17,100.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Odonate Inc | 50.0M | -1,258.5x | --- |
China Health Industries Holdings Inc | 53.1M | -24.5x | --- |
Eyenovia Inc | 46.6M | -1.3x | --- |
Lexaria Bioscience Corp | 45.0M | -4.5x | --- |
Bright Green Corp | 41.2M | -2.9x | --- |
NDT Pharmaceuticals Inc | 36.8M | 0.0x | --- |
Company Information
Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.
Contact Information
- Headquarters
- 3 East 28Th Street, 10Th FloorNEW YORK, NY, United States 10016
- Phone
- 858-200-3830
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Kevin Tang
- Chief Financial Officer
- Michael Hearne
- Director
- Robert Rosen
- Independent Director
- Aaron Davis
- Independent Director
- Laura Douglass
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.9K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.17 |
EPS | $-13.59 |
Book Value | $17.65 |
P/E Ratio | -1,258.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
